Business Strategies
ICYMI: Guardant Updates Liquid Biopsy’s Potential at ASCO
Guardant Health presented close to 30 abstracts at ASCO highlighting the technology’s myriad applications.
Subscribe now to read the full analysisWelcome to MyStrategist, an online experience like no other in the medical device industry.
With MyStrategist, quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and MedTech Strategist Market Pathways – now on an all-in-one, digital platform. We invite you to explore our coverage.
Think Strategically. Subscribe Today.
Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
ADA 2020: Spotlight on Closed-Loop Insulin Delivery Systems, CGM for Type 2s
Automated insulin delivery systems were a highlight of this year’s (virtual) ADA meeting, with presentations on new devices from Medtronic, Tandem Diabetes Care, Insulet, Beta Bionics, and Eli Lilly, all vying for a top spot in this fast-evolving space. Industry analysts opine on their commercial prospects as well as Dexcom and Abbott’s efforts to expand CGM to the type 2 diabetes population.
Subscribe now to read the full analysisRegistration is now open for the 7th annual Innovation Summit Dublin, March 23-25, 2021. The industry's most anticipated event will sell out. Register Today.
Register Learn More
Regulatory & Reimbursement
FDA Output July 2020
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and Diagnostic Emergency Use Authorizations in July 2020. Updated July 13.
Subscribe now to read the full analysis